Tesla Medical, s.r.o. – Trademark Portfolio
Entity Type: 03
Tesla Medical, s.r.o. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ETNM and STIMVIA. The owner is based in Ostrava - Hulvaky.
Sokola Tumy 1099/1
Ostrava - Hulvaky 70900 , CZ
Showing of trademarks Trademarks
Trademark Classifications
Tesla Medical, s.r.o.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Tesla Medical, s.r.o. have?
Tesla Medical, s.r.o. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Tesla Medical, s.r.o. file in?
Tesla Medical, s.r.o. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Tesla Medical, s.r.o.'s most well-known trademarks?
Tesla Medical, s.r.o.'s registered trademark portfolio includes well-known marks such as ETNM and STIMVIA. These are among 2 currently registered trademarks in the portfolio.
What is Tesla Medical, s.r.o.'s trademark registration success rate?
Tesla Medical, s.r.o. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.